Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Severe CCCA may be biologically and clinically different from milder forms.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

Some natural ingredients like onion juice, rosemary oil, and pumpkin seed oil may help with hair growth and reducing hair loss.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Trichoscopy is a useful tool for diagnosing different types of female hair loss without needing a biopsy.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Hair shaft changes may be linked to CCCA, but their role is unclear.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.